Markel vs. Skyward: Which Specialty Insurance Stock Is a Better Buy in 2026?

Recent financial evaluations compare several investment opportunities for 2026. In the specialty insurance sector, Markel is analyzed against Skyward. Within the small-cap value ETF market, Vanguard VBR is weighed against State Street SLYV to determine the superior buy. Additionally, the healthcare industry sees a comparison between DaVita and Encompass Health. These assessments aim to identify which specific stocks and funds offer the best value and growth potential for investors heading into the 2026 fiscal year.